Stockreport

Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Accelerate Upstream Targeted Protein Degradation Platform

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Supported by distinguished Scientific Advisory Board of industry and academic leaders in translational science and drug development PARIS--(BUSINESS WIRE)--Enodia The [Read more]